已收盘 07-10 16:00:00 美东时间
0.000
0.00%
BTIG analyst Ryan Zimmerman reiterates Organogenesis Holdings (NASDAQ:ORGO) with a Buy and maintains $8 price target.
03-26 17:43
Organogenesis Director Arthur S Leibowitz Acquires Common Shares Arthur S. Leibowitz, a director of Organogenesis Holdings Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technolo
03-12 09:46
BTIG analyst Ryan Zimmerman maintains Organogenesis Holdings (NASDAQ:ORGO) with a Buy and lowers the price target from $9 to $8.
02-27 18:35
Organogenesis Holdings (NASDAQ:ORGO) sees FY2026 sales of $350.000 million-$420.000 million vs $543.400 million analyst estimate.
02-27 05:26
Organogenesis Holdings (NASDAQ:ORGO) reported its Q4 earnings results on Thursd...
02-27 05:26
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
Organogenesis Hldgs (NASDAQ:ORGO) will release its quarterly earnings report on...
02-26 03:01
Organogenesis Holdings ( ($ORGO) ) just unveiled an update. On February 18, 202...
02-24 06:56
Organogenesis Names Patrick McGuire Chief Accounting Officer Organogenesis Holdings Inc. appointed Patrick McGuire as Chief Accounting Officer and principal accounting officer, effective immediately. McGuire previously served as the company’s Vice President, Corporate Controller. David Francisco wil
02-24 06:02
Vanda Pharma (NASDAQ:VNDA) is set to give its latest quarterly earnings report ...
02-11 04:01